Here's what lies ahead Drug giant promises $50 billion U.S. investment Drug giant promises $50 billion U.S. investment Bay ...

Genentech is laying off 143 workers in the South San Francisco drugmaker's third layoff round since April 2024. The company, a biotech stalwart owned by the pharmaceutical giant Roche, announced ...

Another biotechnology company has set its sights on the Triangle with major plans to develop obesity drugs. San Francisco-based Genentech plans to create up to 420 high-paying jobs in Holly ...

Bay Area biotech giant Genentech is offering menopause support for employees. The program seeks to personalize support at every stage of the menopause journey. This, as increasing research, points ...

In Bay Area, Gilead cuts 149 positions and Roche's diagnostics division lays off 108 By Kevin Dunleavy Apr 7, 2025 3:29pm Gilead Sciences Roche layoffs Genentech ...

Regor Pharma, a Shanghai-Boston biotech, sold global rights to Genentech for two early-stage CDK inhibitors aimed at breast cancer. Read more here.

Futurelab+ is made possible through a collaborative network of partners led by Genentech and Discovery Education and supported by Bay Area Bioscience Education Community, Jobs for the Future, Ignited ...

(KRON) — Biotech firm Genentech is laying off nearly 100 employees at its South San Francisco headquarters, according to a WARN notice from the California Employment Development Department (E… ...

Genentech, a stalwart of Bay Area biotech, is laying off 93 workers not long after a larger cut. The industry has seen layoff after layoff this summer.

Three years since founding Site Alliance in 2021, Genentech is now sharing data showing sites in the alliance enroll more Black and Hispanic/Latinx patients than other sites in the same studies ...